CIK 0001043961
- Non-accelerated filer
- Smaller reporting company
Precipio, Inc.
Sign in to watch- Ticker
- PRPO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911789357
- Phone
- +1 203-787-7888
- Business address
- 4 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- TRANSGENOMIC INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-11 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-01-04 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-07-02 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +4,000 | 4,000 | ||
| 2020-01-16 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-03-18 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2018-02-16 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +31,025 | 31,025 | ||
| 2018-02-16 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +77,563 | 77,563 | ||
| 2017-10-10 | Rimer Mark Director | Other disposition | −124,496 | 0 | ||
| 2017-10-10 | Rimer Mark Director | Other disposition · Offering Warrant to Purchase Common Stock | −124,496 | 0 | ||
| 2017-10-10 | Rimer Mark Director | Other disposition · Warrant to Purchase Common Stock | −91,420 | 0 | ||
| 2017-09-26 | Rimer Mark Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2017-09-08 | Rimer Mark Director | Grant or award · Offering Warrant to Purchase Common Stock | +124,496 | 124,496 | ||
| 2017-09-08 | Rimer Mark Director | Grant or award · Offering Warrant to Purchase Common Stock | +85,476 | 85,476 | ||
| 2017-09-08 | Rimer Mark Director | Conversion | +85,476 | 686,874 | ||
| 2017-09-08 | Rimer Mark Director | Conversion | +124,496 | 124,496 | ||
| 2017-09-08 | Rimer Mark Director | Conversion · 8% Convertible Promissory Note | −83,301 | $311,241.00 | $25.9B | 0 |
| 2017-09-08 | Rimer Mark Director | Grant or award · Offering Warrant to Purchase Common Stock | +124,496 | 124,496 | ||
| 2017-09-08 | Rimer Mark Director | Conversion · 8% Convertible Promissory Note | −20,073 | $75,000.00 | $1.5B | 0 |
| 2017-09-08 | Rimer Mark Director | Grant or award · Offering Warrant to Purchase Common Stock | +85,476 | 85,476 | ||
| 2017-09-06 | Rimer Mark Director | Other acquisition · 8% Convertible Promissory Note | +83,301 | $311,241.00 | $25.9B | 83,301 |
Page 1 of 2 · 38 trades